Back

LDL-lowering versus LDL eradication; what makes clinical sense

28 August 2018 (13:20 - 13:35)
Organised by:
Congress Presentation Part of: New concepts and models in cardiovascular risk management (EBAC Accredited) Lipids ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor John Kastelein

Academic Medical Centre, Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Introduction - New concepts and models in cardiovascular risk management
Professor P. Libby (Boston, US) Professor J. Deanfield (London, GB)
Presentation thumbnail
Challenges and models in cardiovascular risk management - Start early, invest in your arteries
Professor J. Deanfield (London, GB)
Presentation thumbnail
Precision medicine and tools in high cardiovascular risk patients
Professor F. Visseren (Utrecht, NL)
Presentation thumbnail
Panel discussion - New concepts and models in cardiovascular risk management
Professor P. Libby (Boston, US) Professor J. Deanfield (London, GB)

Access the full session

Session thumbnail
New concepts and models in cardiovascular risk management (EBAC Accredited)

The Event

Event poster

ESC Congress 2018

28 August 2018 13:20 CET
You may be interested in
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)
7 October 2025
thumbnail
Congress Presentation
Risk factors control, remnant cholesterol, recurrent events and risk in patients with coronary heart disease. Our experiences
4 April 2025
thumbnail
Congress Presentation
LDL treatment-years: a new paradigm for cardiovascular risk reduction
1 September 2025
thumbnail
Congress Presentation
Pictorial information about subclinical atherosclerosis reduces the CVD risk: Results from the VIPVIZA RCT
17 April 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources